SCHEMBL28558346

SCHEMBL28558346

Cc1ccc(F)c(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FGFR1 P11362 14/20 0.74
EGFR P00533 11/20 0.74
SRC P12931 11/20 0.74
PDGFRB P09619 8/20 0.74
PDGFRA P16234 8/20 0.74
ABL1 P00519 7/20 0.74
MAPK14 Q16539 7/20 0.74
STAT5A P42229 1/20 0.73
ACVR1 Q04771 1/20 0.73
PKMYT1 Q99640 1/20 0.73
KIT P10721 3/20 0.69
WEE1 P30291 3/20 0.67
FGFR2 P21802 1/20 0.67
FGFR4 P22455 1/20 0.67
FGFR3 P22607 1/20 0.67
PSEN1 P49768 1/20 0.62
PSEN2 P49810 1/20 0.62
APH1B Q8WW43 1/20 0.62
NCSTN Q92542 1/20 0.62
APH1A Q96BI3 1/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5762046 0.85 SRC (1.00) FGFR1EGFRSRCPDGFRBPDGFRA
SCHEMBL29765306 0.85 SRC (1.00) FGFR1EGFRSRCPDGFRBPDGFRA
SCHEMBL30257377 0.85 SRC (1.00) FGFR1EGFRSRCPDGFRBPDGFRA
SCHEMBL29378902 0.85 SRC (1.00) FGFR1EGFRSRCPDGFRBPDGFRA
SCHEMBL256711 0.85 SRC (1.00) FGFR1EGFRSRCPDGFRBPDGFRA
SCHEMBL13498143 0.84 FGFR1 (0.83) FGFR1EGFRSRCPDGFRBPDGFRA
SCHEMBL1334768 0.82 SRC (1.00) FGFR1EGFRSRCPDGFRBPDGFRA
SCHEMBL5764062 0.82 FGFR1 (1.00) FGFR1EGFRSRCPDGFRBPDGFRA
SCHEMBL3360316 0.81 FGFR1 (0.74) FGFR1EGFRSRCPDGFRBPDGFRA
SCHEMBL1249524 0.81 FGFR1 (1.00) FGFR1EGFRSRCPDGFRBPDGFRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112755193-A Method of treating malignancies with anti-tyrosine kinase inhibitors using dianhydrogalactitol or a derivative thereof 德玛医药 2021-05-07 CN disclosed